The Platelet Antibodies, Indirect (IgG, IgM, IgA) panel, which includes the Platelet Ab, Indirect (IgM) test, is a crucial diagnostic tool in the realm of hematology and immunology, specifically for evaluating thrombocytopenia and platelet dysfunction disorders. The Platelet Ab, Indirect (IgM) test focuses on detecting the presence of immunoglobulin M (IgM) antibodies targeting platelets. These IgM antibodies are important in identifying autoimmune conditions and other disorders where the body's immune system erroneously attacks and destroys its own platelets, leading to a reduced platelet count. The presence of IgM platelet antibodies can be indicative of Immune Thrombocytopenia (ITP), a condition where these antibodies bind to platelets, marking them for destruction. This test is also valuable in diagnosing drug-induced thrombocytopenia, where certain medications trigger the production of platelet-specific antibodies, and in conditions like post-transfusion purpura, a rare complication following blood transfusion. The Platelet Ab, Indirect (IgM) test in this panel is instrumental for the accurate diagnosis, monitoring, and management of these disorders. Its ability to detect IgM antibodies against platelets is key to guiding appropriate treatment strategies, such as immunosuppressive therapy or tailored platelet transfusion regimens.
Platelet Ab, Indirect (IgM)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.